Sofinnova Venture Partners IX L.P. 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-03-04 06:17 am Sale | 2020-08-06 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Sofinnova Venture Partners IX L.P. | 0 0.000% | -1,180,178 (Position Closed) | Filing |